IMCR
Price
$35.17
Change
-$0.10 (-0.28%)
Updated
Jul 25 closing price
Capitalization
1.77B
10 days until earnings call
XENE
Price
$30.30
Change
-$0.71 (-2.29%)
Updated
Jul 25 closing price
Capitalization
2.33B
11 days until earnings call
Interact to see
Advertisement

IMCR vs XENE

Header iconIMCR vs XENE Comparison
Open Charts IMCR vs XENEBanner chart's image
Immunocore Holdings
Price$35.17
Change-$0.10 (-0.28%)
Volume$217.8K
Capitalization1.77B
Xenon Pharmaceuticals
Price$30.30
Change-$0.71 (-2.29%)
Volume$969.94K
Capitalization2.33B
IMCR vs XENE Comparison Chart in %
Loading...
IMCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XENE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IMCR vs. XENE commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMCR is a StrongBuy and XENE is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (IMCR: $35.17 vs. XENE: $30.30)
Brand notoriety: IMCR and XENE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMCR: 57% vs. XENE: 83%
Market capitalization -- IMCR: $1.77B vs. XENE: $2.33B
IMCR [@Biotechnology] is valued at $1.77B. XENE’s [@Biotechnology] market capitalization is $2.33B. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMCR’s FA Score shows that 0 FA rating(s) are green whileXENE’s FA Score has 1 green FA rating(s).

  • IMCR’s FA Score: 0 green, 5 red.
  • XENE’s FA Score: 1 green, 4 red.
According to our system of comparison, both IMCR and XENE are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMCR’s TA Score shows that 5 TA indicator(s) are bullish while XENE’s TA Score has 5 bullish TA indicator(s).

  • IMCR’s TA Score: 5 bullish, 5 bearish.
  • XENE’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, XENE is a better buy in the short-term than IMCR.

Price Growth

IMCR (@Biotechnology) experienced а -3.14% price change this week, while XENE (@Biotechnology) price change was -4.08% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.62%. For the same industry, the average monthly price growth was +17.39%, and the average quarterly price growth was +28.36%.

Reported Earning Dates

IMCR is expected to report earnings on Nov 05, 2025.

XENE is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+7.62% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
XENE($2.33B) has a higher market cap than IMCR($1.77B). IMCR YTD gains are higher at: 19.220 vs. XENE (-22.704). IMCR has higher annual earnings (EBITDA): -97K vs. XENE (-290.36M). IMCR has more cash in the bank: 837M vs. XENE (550M). XENE has less debt than IMCR: XENE (8.68M) vs IMCR (434M). IMCR has higher revenues than XENE: IMCR (334M) vs XENE (7.5M).
IMCRXENEIMCR / XENE
Capitalization1.77B2.33B76%
EBITDA-97K-290.36M0%
Gain YTD19.220-22.704-85%
P/E RatioN/AN/A-
Revenue334M7.5M4,453%
Total Cash837M550M152%
Total Debt434M8.68M5,003%
FUNDAMENTALS RATINGS
XENE: Fundamental Ratings
XENE
OUTLOOK RATING
1..100
86
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
PROFIT vs RISK RATING
1..100
48
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
86
P/E GROWTH RATING
1..100
5
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IMCRXENE
RSI
ODDS (%)
Bearish Trend 2 days ago
73%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
82%
MACD
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
78%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
77%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
75%
Advances
ODDS (%)
Bullish Trend 5 days ago
76%
Bullish Trend 10 days ago
72%
Declines
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
74%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
72%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
IMCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XENE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NWAOX36.590.28
+0.77%
Nationwide BNY Mellon Dyn US Eq Inc I.S
HWGIX16.120.11
+0.69%
Hotchkis & Wiley Global Value I
TRZVX53.300.15
+0.28%
T. Rowe Price Small-Cap Value Z
MAICX9.70-0.03
-0.31%
Victory Trivalent Intl Fd-Core Eq A
CDWCX12.44-0.08
-0.64%
American Funds Dvlpg Wld Gr&Inc 529C

IMCR and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMCR has been loosely correlated with XENE. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if IMCR jumps, then XENE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMCR
1D Price
Change %
IMCR100%
-0.28%
XENE - IMCR
48%
Loosely correlated
-2.29%
IDYA - IMCR
48%
Loosely correlated
-1.33%
NRIX - IMCR
48%
Loosely correlated
-0.09%
CRNX - IMCR
46%
Loosely correlated
N/A
KYMR - IMCR
46%
Loosely correlated
-0.13%
More